Chicago HIV Clinical Trials Unit
Chicago Clinical Trials Unit
['FUNDING_OTHER'] · NORTHWESTERN UNIVERSITY · NIH-11234305
A Chicago-based team running clinical trials of new HIV treatments, cure strategies, and long-acting prevention options for adults living with or at risk for HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-11234305 on ClinicalTrials.gov |
What this research studies
This consortium of four Chicago clinical research sites runs studies on adult HIV therapies, cure-related strategies, and comorbidities like hepatitis B and tuberculosis. They also test integrated prevention approaches, including long-acting ARV agents, new delivery systems for PrEP, and antibody-mediated prevention in partnership with vaccine networks. The unit combines biomedical and socio-behavioral methods, manages labs and pharmacies, and works closely with affected communities to recruit and support participants. If you join, you may be asked to try new medications or delivery methods, provide blood and other samples, and complete clinic visits and questionnaires.
Who could benefit from this research
Good fit: Adults (typically 21+ as specified by study protocols) living with HIV or adults at risk for HIV who meet the trial medical and eligibility criteria are the usual candidates.
Not a fit: People under age criteria, those who do not meet the study's medical or laboratory requirements, or those seeking guaranteed personal benefit may not receive direct benefit from participation.
Why it matters
Potential benefit: Successful work could bring more effective HIV treatments, steps toward a cure, and more convenient prevention options such as long-acting injections or improved PrEP delivery.
How similar studies have performed: Prior trials run by NIAID/ACTG networks have led to important HIV treatments and prevention tools (for example oral PrEP and effective ARVs), though some specific new approaches remain experimental.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ACHENBACH, CHAD J — NORTHWESTERN UNIVERSITY
- Study coordinator: ACHENBACH, CHAD J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus